Answers are grounded in this paper and cite their sources.
The drug services company Charles River Laboratories has invested in and partnered with Autobahn Labs, a Palo Alto–based drug discovery start-up, to accelerate academic research in novel therapies. Charles River will help Autobahn partner with top academic institutions as well as grant access to its in-house drug discovery and development capabilities. Charles River's investment was part of a fundraising round led by Autobahn's founding investor, Samsara BioCapital.
No takes yet. Share an insight, caveat, or question.
Aayushi Pratap (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: